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Abstract
Background: Necrotic enteritis is a significant problem to the poultry industry globally and, in Norway up to 30% of
Norwegian turkey grow-outs can be affected. However, despite an awareness that differences exist between necrotic
enteritis in chickens and turkeys, little information exists concerning the pathogenesis, immunity, microbiota or
experimental reproduction of necrotic enteritis in turkeys. In particular, it is important to determine the appearance of
the gross lesions, the age dependency of the disease and the role of netB toxin of Clostridium perfringens. To this end,
we report our findings in developing an in vivo experimental model of necrotic enteritis in turkeys.
Results: A four tier (0–3) scoring system with clearly defined degrees of severity of macroscopic intestinal lesions was
developed, based on 2312 photographic images of opened intestines from 810 B.U.T. 10 or B.U.T. Premium turkeys
examined in nine experiments. Loss of macroscopically recognizable villi in the anterior small intestine was established
as the defining lesion qualifying for a score 3 (severe intestinal lesions). The developed scoring system was used to
identify important factors in promoting high frequencies of turkeys with severe lesions: a combined Eimeria
meleagrimitis and Clostridium perfringens challenge, challenge at five rather than 3 weeks of age, the use of an Eimeria
meleagrimitis dose level of at least 5000 oocysts per bird and finally, examination of the intestines of 5-week-old turkeys
at 125 to 145 h after Eimeria meleagrimitis inoculation. Numbers of oocysts excreted were not influenced by Clostridium
perfringens inoculation or turkey age. Among three different lesion score outcomes tested, frequency of severe lesions
proved superior in discriminating between impact of four combinations of Clostridium perfringens inoculation and
turkey age at challenge.
Conclusions: This study provides details for the successful establishment of an in vivo model of necrotic
enteritis in turkeys.
Keywords: Necrotic enteritis, Challenge model, Turkeys, Macroscopic lesions, Scoring system, Clostridium
perfringens, Eimeria meleagrimitis, Age, Refinement
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Background
Clostridium perfringens-associated necrotic enteritis is
an important disease in intensive poultry farming. The
causative agent [1, 2], pathogenesis [3, 4], role of host
immunity [5] and intestinal microbiota [6, 7], epidemi-
ology [8, 9] and experimental reproduction [10] of this
disease in broiler chickens have been extensively investi-
gated. Necrotic enteritis occurs in turkeys and Clostrid-
ium perfringens has been implicated in the aetiology
[11–15], but little information exists concerning the
pathogenesis [16], immunity, microbiota or experimental
reproduction of turkey necrotic enteritis.
Experimentally-induced necrotic enteritis in chickens
has been critical in the study of the disease [17], and the
lack of an experimental model of turkey necrotic enter-
itis represents an obstacle to improve the understanding
of the disease in that host. Combined administration of
coccidia and Clostridium perfringens is considered an
efficient way of inducing experimental necrotic enteritis
in chickens [10], and similarly the combination may be
useful in turkeys, since data from commercial turkey
flocks suggest a predisposing role of coccidia in turkey
necrotic enteritis [13, 14]. Eimeria meleagrimitis is a
pathogenic coccidium capable of inducing lesions mainly
in the duodenum and jejunum [18]. In our experience
(unpublished data) and according to other workers [11, 15],
the anterior small intestine is most frequently and most
severely affected by necrotic enteritis in turkeys thereby
implicating a predisposing role for Eimeria meleagrimitis in
necrotic enteritis of turkeys.
Scoring systems for macroscopic intestinal lesions are
valuable when assessing impact of influencing factors on
disease outcome in necrotic enteritis models [10]. Ideally
such scoring systems distinguish clearly between degrees
of lesion severity, making it possible to score consistently
within and between experiments. If possible, the scoring
system should also include necrotic enteritis specific
scores. Anterior small intestinal mucosal ulcers/depres-
sions and pseudomembranes are considered necrotic en-
teritis specific macroscopic lesions in chickens [19–21].
These lesions are usually easy to identify and distinguish
from macroscopic lesions caused by coccidia inducing
lesions in the anterior small intestine, but the frequency
of such lesions may be variable in experimental chicken
models. Most chicken models are therefore based on
scoring systems involving additional and less specific
macroscopic criteria. Current knowledge about how to
differentiate between macroscopic intestinal lesions in
turkeys caused by Eimeria meleagrimitis and Clostrid-
ium perfringens is limited.
This work describes a new scoring system with defined
degrees of severity for macroscopic intestinal lesions in
Eimeria meleagrimitis- and Clostridium perfringens-inocu-
lated turkeys, and investigates the impact of Clostridium
perfringens inoculation and other factors on the frequency
of severe lesions in turkeys inoculated with Eimeria
meleagrimitis, as a contribution to the development of a
necrotic enteritis challenge model in turkeys.
Results
A macroscopic scoring system for intestinal lesions
A macroscopic scoring system with four categories (0–3)
was developed. The criteria for each score were as follows:
0 Normally coloured intestinal mucosa. Non-dilated
intestine that everts rapidly and completely after
being opened longitudinally. Normal intestinal
contents. Transparent and inconspicuous villi
(Fig. 1a).
1 Defining characteristic: Pale anterior (entirely or
partly from the gizzard to Meckel’s diverticulum)
Fig. 1 Photos of small intestinal mucosa from turkeys. A: Score 0
(normal). B: Score 1 (mild changes: pale mucosa and increased
amount of watery intestinal contents). C: Score 2 (moderate
changes): swollen, pale villi. D-G: Score 3 (various sub-types of severe
changes). H: Score 3 (mucosal depressions suggesting healing
multifocal necrotic enteritis). Photos A-F and H: Simon P Hardy.
Photo G: Magne Kaldhusdal
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small intestinal mucosa. Intestine may evert
incompletely after longitudinal opening. Villi are
not conspicuous but may be slightly opaque or
swollen, or the intestinal mucosa may be partly
hyperaemic with reddish villi. There is usually
increased amount of non-viscous, transparent fluid
in intestinal contents (Fig. 1b).
2 Recognizable villi are present. The villi are clearly
opaque or swollen and/or the mucosa shows
moderate swelling, oedema or petechial
haemorrhages. There may be blood clots and/or
turbid (often mucoid) non-adherent materials in the
intestinal lumen. Changes found in intestines with
score 1 may also be present (Fig. 1c).
3 Defining characteristic: Loss of recognizable villi
(regenerating villi may be present beneath a
sloughing necrotic mucosa). Severely swollen and
marbled mucosa with glossy surface and/or mucosa
covered diffusely or (multi) focally by adherent
mucoid and semi-solid or dry material that may be
crumbling or sloughing, and/or demarcated
mucosal ulcers or depressions. Distinct intestinal
dilation may be present. Changes found in intestines
with score 1 and 2 may also be present (Fig. 1d-h).
Figure 1 illustrates examples on how intestines were
scored in accordance with this system. Other examples
are provided in Additional file 1: [22].
Effect of study variables on frequency of severe intestinal
lesions and oocyst excretion levels
Challenged and unchallenged turkeys originating from
nine experiments were examined for intestinal lesions at
three or five weeks of age (Table 1 and Additional file 2:
‘Data lesions all turkeys’ [22]). Neither severe lesions
(score3) nor oocysts in intestinal contents were detected
among unchallenged 3-week old turkeys or among 3-
week-old Eimeria meleagrimitis- and Clostridium perfrin-
gens-inoculated turkeys examined 97–99 h after Eimeria
meleagrimitis inoculation ([22], Table 1 and data from
experiments 3 and 4 included in Table 2). Due to the
influencing effects of experiment, turkey age, hours exam-
ined after Eimeria meleagrimitis-inoculation and Eimeria
meleagrimitis dose (see below) on prevalence of turkeys
with severe intestinal lesions, further analyses were re-
stricted to data sets with comparable values of such influ-
encing variables.
Three combinations of Eimeria meleagrimitis and Clostrid-
ium perfringens inoculation were included in experiments 1–
5 (Tables 1 and 2). Data from these five experiments indicate
that a combined Eimeria meleagrimitis- and Clostridium
perfringens-inoculation (EM+CP) of 3-week-old turkeys
induced significantly higher prevalence of birds with severe
lesions (15.5%) than inoculation with Eimeria meleagrimitis
alone (EM, 6.5%). The effects on score3 lesions of Clostrid-
ium perfringens inoculation in Eimeria meleagrimitis-inocu-
lated turkeys at three and five weeks of age are displayed in
Table 3, experiments 1, 4, 7 and 9. The data indicate a
significant increase in percentage of severe lesions from 41.7
to 76.0% in 5-week-old turkeys, corresponding to almost a
doubling of prevalence associated with Clostridium perfrin-
gens inoculation. The percentage increase associated with
Clostridium perfringens inoculation in 3-week-old turkeys
was of similar order, but statistically non-significant. Clostrid-
ium perfringens inoculation had no significant association
with OPG counts (Tables 2 and 3 and Additional file 3: ‘Data
OPG.xlsx’ [22]).
Eimeria meleagrimitis and Clostridium perfringens
challenged turkeys were examined for frequency of
severe intestinal lesions at different time points after
Eimeria meleagrimitis inoculation (Table 2). Severe in-
testinal lesions as well as excreted oocysts were detected
in Eimeria meleagrimitis- and Clostridium perfringens-
inoculated turkeys examined 121–171 h after Eimeria
meleagrimitis inoculation (Tables 2 and 4). In 3-week-
old turkeys inoculated with 1.6 to 15 thousand oocysts
the prevalence of birds with severe lesions was similar in
birds examined at 121–149 h and 168–171 h (Table 2,
data from experiments 3 and 4). Among 3-week-old
turkeys inoculated with 5–20 thousand oocysts, severe
lesions were clearly more common at 123–129 h than at
145–147 h after Eimeria meleagrimitis inoculation (Table 2,
data from experiments 1, 4 and 9). In 5-week-old turkeys
inoculated with 10–20 thousand oocysts, the frequencies of
birds with severe lesions were high and similar at about 125
and 145 h after Eimeria meleagrimitis (Table 2, data from
experiment 9).
The peak frequency of severe lesions in experiments
based on 3-week-old turkeys varied widely (Table 4). A
peak prevalence of at least 40% among 3-week-old turkeys
was achieved in experiments 1 and 4, in birds inoculated
with 5–20 thousand oocysts and examined 123–129 h
after Eimeria meleagrimitis inoculation. A high (46.2%)
prevalence of severe lesions was also found in 3-week-old
turkeys challenged with 1.6 thousand oocysts, in this case
at about 168 h after Eimeria meleagrimitis inoculation
(Table 4, experiment 3).
Experiment 9 was devised to examine the effect of
challenge at two different ages of the turkeys (Tables 2
and 4). The impact of Eimeria meleagrimitis dose and
hours after Eimeria meleagrimitis inoculation was con-
trolled for through design. The results indicate a signifi-
cant and strong (roughly eight to nine times increased
frequency at five weeks of age) impact of turkey age on
percentage of severe lesions (Table 2). There was no
clear difference in prevalence of birds with severe lesions
between turkeys examined 125 and 145 h after Eimeria
meleagrimitis inoculation, although OPG counts differed
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Table 1 Design of the nine experiments in the study
Exp Birds1 Age2 EM CP Hours No. No.
dose3 strain Days4 after EM5 NE6 score36 Mean score7
1 3 17 – – – 127/145/169 0/0/0 0/0/0 0.0/0.0/1.0
3 17 5 – – 0/0/0 0/0/0 0.0/1.0/1.0
3 17 20 – – 1/0/0 1/0/0 3.0/1.0/1.0
15 17 5 04 3,4,5 1/0/0 2/0/0 1.8/1.0/1.0
15 17 20 04 3,4,5 3/0/0 3/0/0 2.2/1.0/1.4
15 17 5 13 3,4,5 1/0/0 1/0/0 1.4/1.0/1.0
15 17 20 13 3,4,5 2/0/1 2/0/1 1.8/1.0/1.4
2 18 17 – – – 99/123/145 0/0/0 0/0/0 0.2/0.2/0.3
18 17 0.25 – – 0/0/0 0/0/0 0.0/0.8/1.3
18 17 0.25 04 3,4 0/0/0 0/0/0 0.0/1.3/1.0
36 17 0.25 04 3,4,5 0/0/0 0/0/0 0.0/1.2/1.3
18 17 0.25 36 3,4,5 0/0/0 0/0/0 0.2/1.2/1.5
3 22 17 – – – 97/121/145/168 0/0/0/0 0/0/0/0 0.2/0.3/0.7/0.5
18 17 1.60 – – 0/0/0/− 0/0/0/− 0.3/0.8/0.5/−
24 17 1.60 04 3,4,5 0/0/1/4 0/0/1/4 0.3/0.6/1.0/3.0
23 17 1.60 13 3,4,5 0/0/0/0 0/0/0/0 0.2/0.8/1.1/2.0
24 17 1.60 36 3,4,5 0/0/0/2 0/0/0/2 0.3/0.4/1.2/2.5
4 8 17 – – – 99/123/147/171 0/0/0/0 0/0/0/0 0.5/0.5/1.0/0.5
21 17 5 – – 0/0/0/0 0/1/0/0 0.5/2.0/1.0/1.0
20 17 15 – – 0/2/0/0 0/3/0/0 1.0/2.8/1.0/1.2
22 17 5 04 3,4,5 0/6/0/1 0/6/0/1 0.8/3.0/1.2/1.5
23 17 15 04 3,4,5 0/6/0/0 0/6/0/0 1.5/3.0/1.2/1.3
24 17 5 13 3,4,5 0/6/0/0 0/6/0/0 1.5/3.0/1.2/1.3
23 17 15 13 3,4,5 0/7/0/0 0/7/0/0 1.0/3.0/1.3/1.0
5 13 17 – – – 119/141 0/0 0/0 0.0/0.0
14 17 5 – – 0/0 0/0 0.9/1.2
14 17 5 04 4 0/0 0/0 1.1/1.0
14 17 5 04 3,4 0/0 0/0 1.0/1.0
13 17 5 04 3,4,5 0/0 0/0 1.0/0.7
6 18 17 10 04 3,4,5 119/142/168 0/0/0 0/0/0 1.1/1.1/0.0
17 17 20 04 3,4,5 0/0/0 0/0/0 1.1/1.3/1.3
7 19 15 15 – – 121/144/168 0/0/0 0/0/0 1.0/1.0/0.5
21 15 15 04 5,6 1/0/0 1/0/0 1.3/1.1/0.9
21 15 15 04 4,5,6 0/0/0 0/0/0 1.0/1.1/0.6
8 29 16 10 01 3,4,5,6 124/132/142/149 0/0/0/0 0/0/0/0 0.8/1.0/1.0/0.4
31 16 10 04 3,4,5,6 0/0/0/0 0/0/0/0 0.8/1.0/1.0/1.0
31 16 10 13 3,4,5,6 0/0/0/0 0/0/0/0 0.9/1.0/1.0/0.9
30 16 10 58,702 3,4,5,6 0/0/0/0 0/0/0/0 0.9/0.8/1.0/0.8
9 12 17 10 – – 125/145 0/0 0/0 1.3/1.0
12 17 20 – – 0/0 0/1 1.5/1.6
12 17 10 04 + 13 3,4,5 0/0 0/0 1.0/1.5
11 17 20 04 + 13 3,4,5 0/0 1/1 2.3/1.7
11 30 10 – – 0/2 2/3 1.5/2.1
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significantly with sampling time (Table 4). OPG counts
did not differ between three and five week old birds.
The effect of Eimeria meleagrimitis dose on percentage
of severe intestinal lesions was examined in two ways; (a)
overall effect of three Eimeria meleagrimitis dose levels
(sampling 121–171 h after Eimeria meleagrimitis) and (b)
the interplay between Eimeria meleagrimitis dose level
and number of hours after Eimeria meleagrimitis inocula-
tion (Table 3). The potential impact of experiment could
not be controlled for, because the lowest levels of Eimeria
meleagrimitis dose (250 and 1600 oocysts per bird) were
employed only in experiments 2 and 3 and the highest
levels (5000 to 20,000 oocysts) were not tested in these
two experiments. Data on overall impact of Eimeria
meleagrimitis dose indicated similar levels of severe
lesions in 3-week-old turkeys inoculated with 5000 and
15–20,000 oocyst, and significantly higher frequencies of
severe lesions in such turkeys as compared to turkeys
inoculated with 250 to 1600 oocysts. Overall OPG counts
were not significantly influenced by Eimeria meleagrimitis
dose (Table 3). Whereas high (5–20 thousand oocysts)
Eimeria meleagrimitis doses were associated with early
(123–129 h) peaks in OPG counts and severe lesions
(Tables 3 and 4, experiments 1 and 4), a low Eimeria
meleagrimitis dose level (1600 oocysts) was associated
with a late (168 h) peak in prevalence of birds with severe
lesions (Tables 3 and 4, experiment 3).
A total of 18 (56%) of the 32 turkeys recorded with
severe (score 3) lesions in experiment 9 had a macro-
scopic appearance suggestive of pseudomembranous
material adherent to the intestinal mucosa or mucosal
ulcers similar to those characteristic of necrotic enteritis
lesions in chickens. All 18 cases were detected among 5-
week-old Eimeria meleagrimitis- inoculated turkeys. The
Table 1 Design of the nine experiments in the study (Continued)
Exp Birds1 Age2 EM CP Hours No. No.
dose3 strain Days4 after EM5 NE6 score36 Mean score7
12 30 20 – – 0/2 2/3 2.0/2.3
13 30 10 04 + 13 3,4,5 1/7 3/7 2.3/2.8
12 30 20 04 + 13 3,4,5 2/4 3/6 2.8/2.6
1Total number of turkeys/treatment group (row), 2Age in days at Eimeria meleagrimitis-inoculation, 3 Number (in thousands) of Eimeria meleagrimitis oocysts
inoculated per bird. Strain pM3 was used in experiments 1–8, strain USSMN08–01-5 was used in experiment 9, 4 CP = Clostridium perfringens, Days = number of
days between Eimeria meleagrimitis-inoculation and Clostridium perfringens-inoculation, 5 Number of hours between Eimeria meleagrimitis-inoculation and post-
mortem examination, 6 Number of birds with the appropriate score (NE =mucosal pseudomembrane, ulcer or depression, score3 = score 3 in the scoring system)
on each sampling occasion after Eimeria meleagrimitis-inoculation, 7 Mean score on each sampling occasion
Table 2 Effect of sampling time, challenge and age on frequency of severe intestinal lesions
Study variable Study variable level CP1 EM dose2 Hours after EM3 Experiments No. of birds (gut contents)4 % score3 OPG5
Hrs post 97–99 1 1.6–15 – 3,4 34 (10) < 3.0a 0a
EM6 121–149 1 1.6–15 – 3,4 91 (20) 29.7b 5.8b
(3-wk-old) 168–171 1 1.6–15 – 3,4 38 (9) 18.4ab 5.0b
123–129 1 5–20 – 1,4,9 53 (16) 64.2c 6.3e
145–147 1 5–20 – 1,4,97 59 (10) 1.7d 5.4e
125 1 10–20 – 9 8 (2) 12.5g 4.6e
145 1 10–20 – 9 15 (2) 6.7g 6.2f
(5-wk-old) 125 1 10–20 – 9 8 (2) 75.0c 4.6e
145 1 10–20 – 9 17 (2) 76.5c 6.1f
Challenge None 0 0 119–171 1,2,3,4,5 50 (12) < 2.1a 0a
(3-wk-old) EM8 0 0.25–20 119–171 1,2,3,4,5 77 (16) 6.5a 5.5b
EM + CP9 1 0.25–20 119–171 1,2,3,4,5 278 (43) 15.5b 5.6b
Turkey age 3-wk-old 1 10–20 125–145 9 23 (8) 8.7c 5.8e
5-wk-old 1 10–20 125–145 9 25 (8) 76.0d 5.6e
1Clostridium perfringens inoculation (0 = no, 1 = yes) status of lesion scored birds, 2 Number (in thousands) of inoculated Eimeria meleagrimitis oocysts per bird, 3
number of hours elapsed between Eimeria meleagrimitis inoculation and examination of turkeys, 4 Number of bird scored for intestinal lesions (number of pooled
samples of intestinal contents examined for OPG), 5 Median log10 of oocysts per gram intestinal contents, based on samples of contents from posterior small
intestine (from Meckel’s diverticulum to caeco-intestinal junction), caeca and colorectum from Eimeria meleagrimitis-inoculated turkeys, 6 Hours elapses between
Eimeria meleagrimitis inoculation and examination for intestinal lesions, 7 OPG data from experiments 4 and 9, 8 Inoculated with Eimeria meleagrimitis, 9 Inoculated
with Eimeria meleagrimitis and Clostridium perfringens
a-bDunn’s test with Bonferroni adjustment of p-values for multiple comparisons, c-dPearson chi-square test, e-fKruskal-Wallis rank test, gFisher’s exact test. Different
letters indicate significant (p < 0.05) difference
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highest prevalence of severe lesions (76%) and classic NE
lesions (pseudomembrane/ulcer/depression, 56%) was
found in 5-week-old turkeys that were inoculated with
Clostridium perfringens. No classic NE lesions were
present among 3-week-old turkeys from experiment 9
(Table 5). However, such lesions were detected in 9.2%
of 3-week-old turkeys that had been inoculated with
Eimeria meleagrimitis and Clostridium perfringens and
were examined 123–171 h after Eimeria meleagrimitis
inoculation ([22], see e.g. Fig. 1F and H).
Comparison of statistical power of outcome variables
Median lesion score, percent severe lesions and percent
mucosal pseudomembranes/ulcers/depressions were com-
pared as outcome variables, based on data from experi-
ment 9 (Table 5 and Additional file 4: ‘Data experiment 9’
[22]). All three outcome variables indicated that 5-week-
old turkeys inoculated with Clostridium perfringens had
more pronounced intestinal lesions than the other three
groups, although this difference was significant only for
percent severe lesions and percent pseudomembranes/ul-
cers/depressions.
Median lesion scores showed a numeric increase from
group 0 to 3. The numeric differences between turkeys
with and without Clostridium perfringens-inoculation
(within age group) were not statistically significant, but
the impact of age was significant in turkeys with and
without Clostridium perfringens-inoculation.
The percentage of severe lesions showed a more
marked increase than median lesion score from group 0
to 3, and in this case Clostridium perfringens inoculation
had a significant impact in 5-week-old turkeys. This
lesion type also distinguished between 5-week-old and
3-week-old turkeys, whether they were inoculated with
Clostridium perfringens or not.
Pseudomembranes/ulcers/depressions distinguished
between 5-week-old turkeys that were inoculated with
Clostridium perfringens or inoculated with Eimeria melea-
grimitis alone, but did not differentiate between the three
other combinations of turkey age and Clostridium perfrin-
gens inoculation.
Adverse events and baseline data prior to treatment and
testing
The turkeys were clinically healthy before challenge in all
but one experiment. In experiment 8 there was increased
mortality during the first half of week 2 with a peak on
day 9. The cause was possibly a combination of two fac-
tors; (a) a change from bell drinkers to nipple drinkers on
day 6 may have reduced water uptake temporarily and (b)
the sodium contents of the feed was higher than recom-
mended by the breeder company (0.47 vs 0.17%). A new
batch of feed was offered as from day 9.
Table 3 Effect of Clostridium perfringens and Eimeria meleagrimitis on frequency of severe intestinal lesions
Study variable Study variable level EM dose1 Hours after EM2 Experiments No. of birds (gut contents) % score3 OPG3
CP4 No 10–20 125–145 1,4,7,95 33 (6) 6.1c 5.8e
3-wk-old Yes 10–20 125–145 1,4,7,95 57 (8) 12.3c 6.0e
No 10–20 125–145 9 24 (4) 4.2c 5.8e
Yes 10–20 125–145 9 23 (4) 8.7c 5.5e
5-wk-old No 10–20 125–145 9 24 (4) 41.7c 5.3e
Yes 10–20 125–145 9 25 (4) 76.0d 5.7e
EM dose6 0.25–1.6 – 121–168 2,3 101 (21) 6.9a 5.6a
(thousands) 5 – 123–171 1,4 68 (15) 25.0b 5.4a
15–20 – 123–171 1,4 68 (15) 27.9b 5.5a
Low dose 0.25–1.6 – 121–123 2,3 44 (9) < 2.3a 4.5a
dynamics – 145 2,3 45 (9) 2.3a 6.1b
– 168 3 12 (3) 46.2b 6.2b
High dose 5–20 – 123–129 1,4 45 (12) 73.3a 6.5a
dynamics – 145–147 1,4 44 (6)7 < 2.3b 5.2b
– 169–171 1,4 47 (12) 6.4b 4.9b
1Numbers (in thousands) of inoculated Eimeria meleagrimitis oocysts per bird, 2 Number of hours elapsed between Eimeria meleagrimitis inoculation and
examination of turkeys, 3Median log10 of oocysts per gram intestinal contents, based on samples of contents from posterior small intestine (from Meckel’s
diverticulum to caeco-intestinal junction), caeca and colorectum from Eimeria meleagrimitis-inoculated turkeys 4 Clostridium perfringens inoculation, 5 OPG counts
based on data from experiments 1, 7 and 9, 6 3-week-old Eimeria meleagrimitis-inoculated and Clostridium perfringens-inoculated turkeys, 7 OPG data only from
experiment 4
a-bDunn’s test with Bonferroni adjustment of p-values for multiple comparisons. Different letters indicate significant (p < 0.05) difference, c-dPearson chi-square
test. Different letters indicate significant (p < 0.05) difference, eKruskal-Wallis rank test. Different letters indicate significant (p < 0.05) difference
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OPG of freshly voided faeces was measured on the day
before Eimeria meleagrimitis challenge in experiments 1,
4, 6, 7, 8 and 9, with negative results.
Clinical findings following challenge was recorded in
experiments 1 and 4; a few challenged birds vomited in
association with handling during second or (most often)
third Clostridium perfringens inoculation.
Discussion
The ideal outcome variable in an in vivo model of turkey
necrotic enteritis would be 100% specific for necrotic en-
teritis and possible to record without killing or harming
the bird. Such an outcome variable is hardly achievable
at present, but macroscopic intestinal lesions specific for
necrotic enteritis would be a useful substitute. However,
Table 4 Frequency of turkeys with severe intestinal lesions and OPG counts
Experiment (turkey age) EM dose1 Hours after EM2 No. of scored birds
(samples of intestinal contents)
Percent score33 Median log10 OPG
4
1 5–20 127–129 22 (6) 40.9c 6.3a
(3-wk-old) 145 22 (−) < 4.5d –
169 22 (6) 4.5d 5.3b
2 0.25 123 24 (5) < 4.2a 5.0a
(3-wk-old) 145 24 (5) < 4.2a 5.6a
3 1.6 121 20 (4) < 5.0c 0c
(3-wk-old) 145 20 (4) 5.0c 6.4d
168 13 (3) 46.2d 6.2cd
4 5–15 123 25 (6) 100.0c 6.5a
(3-wk-old) 147 24 (6) < 4.2d 5.2b
171 27 (6) 7.4d 4.7b
5 5 119 23 (4) < 4.3a 4.8a
(3-wk-old) 141 18 (4) < 5.6a 6.0b
6 10–20 119 17 (2) < 5.9c 3.7c
(3-wk-old) 142 13 (2) < 7.7c 6.0c
168 5 (2) < 20.0c 6.0c
7 15 121 14 (3) 7.1c 6.2c
(3-wk-old) 144 14 (3) < 7.1c 5.8c
168 14 (3) < 7.1c 5.9c
8 10 124–132 64 (16) < 1.6a 5.8a
(3-wk-old) 142–149 57 (16) < 1.8a 5.9a
9 10–20 125 8 (4) 12.5a 4.6a
(3-wk-old) 145 15 (4) 6.7a 6.2b
(5-wk-old) 125 8 (4) 75.0a 4.6a
145 17 (4) 76.0a 6.1b
1Numbers of Eimeria meleagrimitis oocysts (in thousands) inoculated per bird, 2 Number of hours elapsed between Eimeria meleagrimitis inoculation and
examination of turkeys, 3 Eimeria meleagrimitis- and Clostridium perfringens-inoculated birds, 4 Eimeria meleagrimitis-inoculated birds
a-bKruskal-Wallis rank test. Different letters indicate significant (p < 0.05) difference, c-d Dunn’s test. Different letters indicate significant (p < 0.05) difference
Table 5 Comparison of statistical power of three different macroscopic outcome variables1
Group Turkey
age
Clostridium perfringens
inoculation
No. of
turkeys
Median (mean) lesion
score
% severe
lesions
% pseudomembrane or ulcer/
depression
0 3 weeks No 24 1.5a (1.33) 4.2a < 4.2a
1 Yes 23 2.0ab (1.61) 8.7ab < 4.4a
2 5 weeks No 23/242 2.0bc (2.04) 41.7b 16.7a
3 Yes 25 3.0c (2.64) 76.0c 56.0b
1Median score, percentage of birds with severe lesions and percentage of birds with pseudomembrane/ulcer/mucosal depression as outcome variables. Four
combinations of turkey age (3-week-old or 5-week-old) and Clostridium perfringens inoculation (with or without Clostridium perfringens inoculation) as study
variable. Data from experiment 9. All birds were Eimeria meleagrimitis-inoculated (10 or 20 thousand oocysts per turkey), 2 Data from 23 turkeys for ‘score’ variable
(missing value for one turkey), and from 24 turkeys for ‘% severe lesions’ and ‘% pseudomembrane or ulcer/depression’
a-cDunn’s test for multiple comparisons. Different letters indicate significant (p < 0.05) difference
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the nature of such lesions in turkeys has not been de-
fined. Macroscopic intestinal ulcers, mucosal depressions
and mucosal necrosis/pseudomembranes are considered
specific for necrotic enteritis in chickens [17, 20, 21]. In
spite of this, many studies of experimental necrotic
enteritis in chickens employ less specific lesions as part
of their scoring system, often with four to seven degrees
of severity [10] and not always with a clear definition of
the characteristics of each degree. Although a common
standard system of lesion scoring in chickens has been
proposed [17] and would be very useful, such a system
has not yet been established [10]. A contribution to-
wards a common scoring system would be that each
grade in the scoring system is clearly defined with a
characteristic property. A major hindrance to creating
such definitions is probably the fact that not only the
severity but also the extent of lesions often is highly
variable. Scoring each bird according to the most severe
lesion type but not according to extent of lesions is one
way of simplifying this task. Another challenge is the
variation in lesion severity between experiments and also
between sampling occasions within each experiment.
This problem could be substantially reduced if the scor-
ing was based on photographs instead of records made
during necropsy. Such a procedure is not without draw-
backs (in particular the lack of possibility to manipulate
the intestine and view the lesions from different angles
at the moment of scoring), but these drawbacks are
probably minor as compared to the advantage of being
able to compare birds across sampling occasions and
experiments as a means of calibration. Furthermore, if
consensus-based scoring systems are established for
necrotic enteritis (in turkeys as well as in chickens),
published photographs based on such systems can be
used to calibrate scoring practices of different studies
and research groups. In this study we have developed and
used a scoring system following the above-mentioned pro-
posed approaches, and we have at the same time taken
into account the fact that necrotic enteritis-specific lesions
have not yet been defined in turkeys.
Scoring systems should produce data allowing for useful
statistical analyses. Two main types of outcome variables
have been used to measure impact of study variables on
necrotic enteritis in chickens; mean/median lesion score
and frequency of specific lesion types (e.g. percentage of
individuals with necrotic enteritis-specific lesions). In this
study, we have focused on a frequency-based outcome, but
we have also included an analysis based on median lesion
scores as outcome, for comparison with two frequency-
based outcome variables (percentage of score 3 lesions and
percentage of pseudomembranes/ulcers/depressions). The
scoring system developed in this study includes well-
defined degrees based largely on villus morphology, and at
least one (score 1) and possibly two (scores 1 and 2) scores
likely to be associated with Eimeria meleagrimitis but not
Clostridium perfringens. Percentage of pseudomembranes/
ulcers/depressions is an outcome considered most likely to
be associated with Clostridium perfringens based on pub-
lished literature on chicken NE, but based on published
papers on lesions in turkeys associated with Eimeria melea-
grimitis [e.g. 18] this agent cannot be excluded as a causa-
tive factor of such lesions. Score 3 lesions is the most
severe lesion degree of our newly developed scoring system,
and includes pseudomembranes/ulcers/depressions as well
as other types of lesions. The comparison of these three
outcome variables (Table 5) suggested that percentage of
score 3 (severe) lesions was the most useful regarding statis-
tical discrimination based on analysed data. This outcome
variable gave unique p-value based superscripts (a-c) to
three of four combinations of Clostridium perfringens in-
oculation and age, whereas the two other outcomes gave
unique superscripts to two study variable combinations.
Frequency of score 3 lesions might therefore be useful in
studies on experimental necrotic enteritis in turkeys in
general.
A main aim of this study was to evaluate the role of
factors that might be important to take into consider-
ation in the design of a challenge model of necrotic
enteritis in turkeys. Two types of such factors were eval-
uated statistically; (a) causative factors or factors with a
likely influencing effect on necrotic enteritis and (b) a
factor that was likely to be important with regard to
detection of necrotic enteritis occurrence in the birds.
Potentially causative or influencing factors that were
evaluated included Clostridium perfringens inoculation
(yes/no), Eimeria meleagrimitis inoculation (yes/no),
Eimeria meleagrimitis dose (ranging from 0.25 to 20
thousand oocysts) and turkey age (3 or 5 weeks). A fac-
tor affecting the likelihood of detecting necrotic enteritis
occurrence was sampling time after Eimeria meleagrimi-
tis inoculation (ranging from 97 to 171 h).
Our data indicate the importance of combining
Eimeria meleagrimitis and Clostridium perfringens (3–5
days after Eimeria meleagrimitis) inoculation as a means
of increasing the frequency of turkeys with severe intes-
tinal lesions (score 3). Clostridium perfringens inocula-
tion had no statistically significant impact on OPG
counts suggesting that Clostridium perfringens did not
affect parasite replication; this observation supports the
assumption that severe lesions were caused principally
by Clostridium perfringens.
Sampling time after Eimeria meleagrimitis and Clostrid-
ium perfringens inoculation was an important predictor of
frequency of turkeys with severe lesions. Sampling four
days (97–99 h) after Eimeria meleagrimitis inoculation
was obviously too early. Although severe intestinal lesions
were detected as early as 121 h after Eimeria meleagrimitis
inoculation, our data [22] suggest that sampling earlier
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than 123 h after Eimeria meleagrimitis implies a risk of
missing many birds with imminent lesion development. In
3-week-old turkeys inoculated with five to 20 thousand
oocysts, the highest prevalence of birds with severe lesions
were found 123–129 h after Eimeria meleagrimitis inocu-
lation, but in 5-week-old turkeys there was no significant
difference in prevalence between birds sampled at 125 and
145 h after Eimeria meleagrimitis (Table 2). For practical
reasons we did not examine turkeys between 132 and 141 h
after Eimeria meleagrimitis inoculation, but our data sug-
gest that this time window comprised peak or near-peak
frequencies of birds with severe lesions among 5-week-old
turkeys inoculated with 10 to 20 thousand oocysts.
The predisposing effect of Eimeria meleagrimitis inocu-
lation on frequency of 3-week-old turkeys with severe
lesions appeared to depend on Eimeria meleagrimitis dose
level (Table 3). The prevalence of birds with severe lesions
was clearly lower in experiments with low (250 to 1600
oocysts per bird) Eimeria meleagrimitis dose levels than in
experiments with high (5000 to 20,000 oocysts per bird)
dose levels. Eimeria meleagrimitis dose also appeared to
influence the dynamics of lesion expression and OPG
counts in 3-week-old turkeys. High Eimeria meleagrimitis
dose levels were associated with peak prevalence of birds
with severe lesions at 123–129 h while low Eimeria melea-
grimitis dose levels were associated with peak prevalence
at 168 h after Eimeria meleagrimitis (Table 3). These data
suggest that the timing of peak expression of severe
lesions can be manipulated by Eimeria meleagrimitis dose,
but possibly not without also affecting the frequency of
birds with such lesions. The effect of high vs low Eimeria
meleagrimitis dose level was not examined in 5-week-old
turkeys.
Challenge of 3-week-old turkeys was part of the design
of all nine experiments. There was variability between
experiments in peak prevalence of turkeys with severe
intestinal lesions that was not explained by the above
mentioned study variables (Eimeria meleagrimitis and
Clostridium perfringens inoculation, Eimeria meleagrimi-
tis dose level and Time of sampling after challenge), as
can be seen by comparing results from experiments 1, 4,
8 and 9 (Table 4). We suspected that the highly variable
prevalence among 3-week-old turkeys could be associ-
ated with the age of the birds, e.g. because of variable
levels of maternal antibodies at this age. Data from ex-
periment 9 support this assumption, because prevalence
of severe lesions was clearly higher among 5-week-old
than 3-week-old turkeys in this experiment (Table 2).
We considered a potentially confounding role of unex-
plained variability in intestinal Eimeria meleagrimitis
proliferation (measured as OPG counts), but the fact
that OPG counts of 3- and 5-week old turkeys were
similar (Table 2) indicate that this assumption could not
be confirmed. In conclusion, our data suggest that Eimeria
meleagrimitis inoculation at days 15–17 followed by
Clostridium perfringens inoculation at days 19–22 (i.e. 3-
week-old birds) carries with it a substantial risk of low
frequencies of severe lesions (Tables 3 and 4) and even
lower levels of pseudomembrane/ulcer/depression frequen-
cies. Further work with in vivo models of turkey necrotic
enteritis should therefore test the reproducibility of the age
effect demonstrated in experiment 9.
Score 3 intestinal lesions were detected in turkeys that
were inoculated with Eimeria meleagrimitis only, in
particular in turkeys examined around five weeks of age
(Table 3). A similar impact of poult age on expression of
lesions in the upper intestinal tract of Eimeria meleagri-
mitis- but not Clostridium perfringens-inoculated turkeys
was documented in a recent work performed at the
laboratory of one of the co-authors (JRB) [23]. These
findings do not preclude the possibility that Clostridium
perfringens colonization is a precondition for the emer-
gence of all or some subtypes of severe (score 3) lesions.
Colonization of the small intestine by environmental
Clostridium perfringens strains is typical [15] unless the
birds are offered sterilized feed and water and kept and
managed in an appropriate way in isolators designed for
germfree birds. Birds raised on litter as was the case in
the present study, are more likely to be colonized than
birds reared on a wire floor. As long as our knowledge
about the prevalence of virulent environmental turkey
Clostridium perfringens strains is insufficient [15, 16], a
role of environmental Clostridium perfringens strains in
lesion induction cannot be ruled out.
The aetiology of score 3 lesions is not fully clarified by
our data. Data from experiment 9 (Table 5) indicate that
the group of turkeys with intestinal pseudomembranes
and ulcers also was the group with highest percentage of
score 3 lesions, at the same time as groups with lower
levels of score 3 lesions had lower prevalence or were
devoid of pseudomembranes/ulcers/depressions. These
findings support the assumption that not only pseudo-
membranes/ulcers/depressions, but also other types of
score 3 lesions are caused by Clostridium perfringens
and constitute part of the complete portfolio of intestinal
changes found in turkey necrotic enteritis. However,
intestinal pseudomembranes in turkeys have been at-
tributed to Eimeria meleagrimitis [18], and more
work is needed to establish the role of Clostridium
perfringens in the development of score 3 types of lesions
and to clarify features of these severe lesions that are nec-
rotic enteritis-specific.
A scoring system based on clearly defined grades, an
optimal time of sampling after challenge, use of photos
facilitating calibration of scoring and outcome variables
maximising statistical power are all factors contributing
to refinement and reduction of the use of turkeys in re-
search on necrotic enteritis. Increased application of at
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least some of these factors in the further development of
necrotic enteritis models in chickens may be useful.
Conclusions
In this study we have developed a scoring system for use
in experimental turkey necrotic enteritis with Eimeria
meleagrimitis as a predisposing factor. We used this
scoring system to demonstrate the impact on macro-
scopic intestinal lesion induction of Clostridium perfrin-
gens inoculation, Eimeria meleagrimitis inoculation,
Eimeria meleagrimitis dose level, turkey age and time
elapsed between Eimeria meleagrimitis challenge and
examination of the intestine. This study represents a first
and major step forward in the development and use of
in vivo experimental models of necrotic enteritis in tur-
keys, and a basis for acquisition of new knowledge about
the pathogenesis, immunity, microbiota and other im-
portant aspects of this disease.
Methods
Study design
This study can be divided into two phases. The first phase
comprised experiments number 1–8 and was based on
the examination of 3-week-old turkeys (Table 1). The fol-
lowing study variables were tested: Eimeria meleagrimitis
inoculation (yes/no), Eimeria meleagrimitis dose (250,
1600, 5000, 10,000, 15,000, 20,000 oocysts per turkey),
Clostridium perfringens inoculation (yes/no) and number
of hours elapsed between Eimeria meleagrimitis inocula-
tion and examination of the turkeys (varied from 97 to
171 h). Three combinations of Eimeria meleagrimitis and
Clostridium perfringens challenge were tested during
phase 1: (a) turkeys with neither Eimeria meleagrimitis
nor Clostridium perfringens challenge, (b) turkeys inocu-
lated with Eimeria meleagrimitis alone and (c) turkeys in-
oculated with Eimeria meleagrimitis and subsequently
with Clostridium perfringens.
The second phase comprised experiment number 9,
with testing of the following four binary study variables:
Clostridium perfringens inoculation (yes/no), Eimeria
meleagrimitis dose (10,000 or 20,000 oocysts per turkey),
turkey age (three or five weeks at necropsy) and number
of hours elapsed between Eimeria meleagrimitis inocula-
tion and examination (125 or 145 h).
Sample size estimation was based on the assumption
that a frequency of challenged individuals would show
severe macroscopic intestinal lesions (primary experi-
mental outcome) that were absent in unchallenged indi-
viduals. Frequency of lesions was likely to be associated
with time of examination after challenge. Because opti-
mal time point for examination was unknown, we exam-
ined birds on two to four occasions per experiment. The
sampsi procedure of Stata 13 was used to explore sample
sizes based on a significance level 0.05 and a power of
0.90. These calculations indicated sample sizes varying
from 5 to 47 depending on expected lesion frequency
(90–20%) in the positive control group and whether the
test was one-sided or two-sided. Although higher statis-
tical power would have been desirable, we decided to
design the study with sample sizes per time point and
experiment that varied between five and eight in
most treatment groups (Table 1), corresponding to
90–75% occurrence of severe intestinal lesions in the
positive control group. The statistical power was
increased by merging treatments groups within
experiments (Tables 4 and 5, and Table 2: Turkey
age). Furthermore, because we conducted a total of
nine experiments, we could increase sample size by
merging observations from identical treatments in
different experiments (Tables 2 and 3).
Animals, housing and feed
Day-old male turkeys (B.U.T. 10 in experiments 1–8,
B.U.T. Premium in experiment 9) were supplied by a
commercial hatchery (Baastad Kalkun, 1866 Båstad,
Norway). The birds arrived in one or two transportation
boxes, and were selected at random for allocation to
experimental groups. In each experiment, all birds origi-
nated from the same parent flock. One day before chal-
lenge, bird size of all treatment groups was compared
visually, and birds were moved in order to make the
average bird size of each treatment group as equal as
possible. All turkeys were kept on floor covered by wood
shavings (new at the beginning of each experiment) dur-
ing the entire experimental period, and were housed
either in up to 21 cages (0.300m2) or up to 10 pens
(1.135m2). Cages were used in experiments 1–4 and pens
were used in experiments 5–9. Maximum estimated total
live weight per m2 during each experiment was 10.0 kg
and 10.9 kg for cages and pens, respectively. Total live
weight estimates were based on Commercial Performance
Objectives of B.U.T. 10 and B.U.T. Premium (http://www.
aviagenturkeys.com/en-gb/documents) as well as record-
ings of actual live weights. The birds had free access to
drinking water and feed, continuous light during the first
24 h after housing and an eight-hours darkness/16-h light
cycle during the rest of each experiment.
All turkeys in this study were euthanized, either be-
cause of disease/disorders, retarded growth or (in most
cases) sampling for data collection. Birds were eutha-
nized by blunt force trauma to the head, to render un-
consciousness, followed by cervical dislocation.
Room temperature was monitored daily and adjusted
with bird age according to guidelines from the hatchery.
No anaesthetics or surgical interventions requiring an-
aesthetics were used in this study. All experiments, in-
cluding the method of euthanasia, were approved by the
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Norwegian Food Safety Authority (FOTS applications ID
5373, 5394 and 10,491).
Experimental feeds were used in experiments 1–7. In
experiments 1–6 a starter feed was used until day 15–17,
followed by a grower feed until the end of the experiment.
In experiment 7 the grower feed was used from day 0
throughout the experiment. Major ingredients of the
experimental starter feed were maize, dehulled oats, ex-
tracted soybean meal and fishmeal. Major ingredients of
the experimental grower feed were wheat, barley, fishmeal,
extracted soybean meal and animal fats. In experiments 8
and 9 all birds were offered a single type of commercial
feed for meat type poultry. Major ingredients were wheat,
oats, extracted soybean meal, maize grits, maize gluten,
fishmeal, animal fats and vegetable fats. None of the used
feeds were supplemented with any antibiotics or anticocci-
dial compounds.
Preparation of inoculum and inoculation
Two strains of Eimeria meleagrimitis were used. Only
one strain was used in each experiment. Strain pM3 was
used in experiments 1–8 and strain USMN08–01-Line 5
was used in experiment 9. Strain pM3 was obtained
from a turkey farm in Brittany, France and purified from
one single oocyst in 1999. The strain has been main-
tained at the Ploufragan-Plouzané-Niort Laboratory of
Anses (French agency for food, environmental and occu-
pational health and safety) by regular passages in turkeys
free from coccidia since it was obtained. Strain USMN08–
01-5 was obtained from a turkey farm in Minnesota, USA
in 2008, isolated and propagated at the University of
Arkansas in Fayetteville, USA, and further characterized at
the University of Guelph in Ontario, Canada [18]. Oocysts
were kept in potassium dichromate suspension at 4°C
until the inoculum was prepared within 24 h of use. In
experiments 1–7 the oocyst suspension was centrifuged at
1300×g for 10min, the supernatant with potassium di-
chromate was removed and the oocysts were resuspended
in PBS. Oocyst concentration was then estimated based
on counts in a Fuchs Rosenthal chamber, and adjusted by
adding PBS if necessary. Suspensions were thoroughly
homogenized immediately prior to every step of sampling
and dilution. Oocysts with morphologic signs suggesting
lack of infectivity/viability were not included in the counts.
At least six samples from each dilution were counted. In-
oculum in experiments 8 and 9 were prepared in the same
way as in experiments 1–7 with the following exceptions:
the original suspension was not centrifuged and potassium
dichromate was not removed.
A total of five Clostridium perfringens isolates (001,
004, 013, 036 and 58,702) were used. All of these isolates
were recovered from severe intestinal lesions in commer-
cial Norwegian turkeys diagnosed with necrotic enteritis.
Isolate 01 was used in one experiment, isolate 04 in all
experiments, isolate 13 in five experiments, isolate 36 in
two experiments and isolate 58,702 in one experiment. In
experiments 1–8 each Clostridium perfringens -challenged
bird was inoculated with only one Clostridium perfringens
isolate. In experiment 9 each challenged bird was inocu-
lated with a mix of isolates 04 and 13.
Clostridium perfringens was inoculated into 200ml
pre-reduced and pre-warmed Brain Heart Infusion broth
(BHI) and incubated anaerobically at 37o C overnight
(15 h) when it was diluted 1 in 2 with fresh BHI. This
inoculum was introduced to the birds within 2 h of prep-
aration. Clostridium perfringens challenge was done on
day three to six after Eimeria meleagrimitis inoculation,
in most cases (see Table 5) on days 3, 4 and 5 after
Eimeria meleagrimitis inoculation.
Eimeria meleagrimitis and Clostridium perfringens
inoculates were administered into the crop of each bird,
using a flexible plastic tube fitted onto a syringe. Low-
dose Eimeria inoculation was conducted prior to high-
dose inoculation. Hygienic measures were taken to avoid
cross-contamination between treatment groups. Control
birds were left un-inoculated.
Sampling, data recording and laboratory analyses
A total of 810 turkeys were moved from the experimental
facility and euthanized (see above for details), examined
and sampled during varying time periods following Eimeria
meleagrimitis and Clostridium perfringens inoculation. The
turkeys were put down and examined at 21 to 36 days of
age. The small intestine between the gizzard and Meckel’s
diverticulum of all birds was opened and inspected closely
for mucosal lesions. If severe lesions were detected in the
posterior part of the opened intestinal segment, the
unopened part of the small intestine was opened and
inspected for lesions. Lesions that were considered severe
or suggestive of necrotic enteritis were recorded. At least
one digital photograph of the opened intestine of each
turkey was taken and used for the development of a scoring
system and subsequent final scoring of each bird. The
turkeys were examined for intestinal lesions on days 4–7
(about 97–171 h) after Eimeria meleagrimitis inoculation,
or at corresponding age in non-inoculated turkeys. A
majority of the turkeys were examined on day 5 or 6 after
Eimeria meleagrimitis inoculation, in most cases corre-
sponding to the last day of Clostridium perfringens inocula-
tion and the day after (Table 1).
Intestinal contents (posterior small intestine from Meckel’s
diverticulum to the caeco-intestinal junction, caeca and col-
orectum) were pooled from birds that were sampled on same
occasion and had identical combination of Eimeria meleagri-
mitis and Clostridium perfringens challenge (including Clos-
tridium perfringens isolate). Collectively these 152 pooled
samples originated from 97.2% (787/810) of all turkeys that
were examined for intestinal lesions. The mean number of
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individuals contributing to each pooled sample was 5.2. OPG
counts were calculated based on routine laboratory proce-
dures using a modified McMaster flotation technique and
Whitlock Universal McMaster counting chambers.
Scoring system development and scoring
Development of the macroscopic lesion scoring system
was based on written records of necropsy findings and
inspection of 2312 photographic images of opened intes-
tines from the examined birds. A four tier scoring
system was devised, graded by lesion severity. A score 0
was given to turkeys with a small intestine considered
macroscopically normal. A score 1 was given to turkeys
with the mildest lesions, and a score 3 was given to tur-
keys with the lesions considered most severe. Important
aspects used to form the four lesion categories include
characteristics of the intestinal wall, mucosa, mucosal
villi, intestinal contents and materials on the mucosal
surface. Scores 1 and 3 were defined by one characteris-
tic lesion type that was not present in birds with lower
scores (but could be present in birds with higher scores).
Scoring of each turkey was conducted after the scoring
system had been established.
Relationships between study variables and frequency of
severe intestinal lesions
The experimental unit was individual turkeys. The pri-
mary experimental outcome was recorded as presence
or absence of score 3 lesions (a binary variable). Out-
come estimates were reported as percentage of examined
turkeys with lesion score 3.
The role of six independent variables in potentially
influencing the primary outcome variable was examined:
Challenge (categorical, 3 combinations of Eimeria melea-
grimitis/Clostridium perfringens inoculation), Eimeria
meleagrimitis dose (categorical, 2 or 3 levels), Clostridium
perfringens inoculation (binary), Hours elapsed between
Eimeria meleagrimitis inoculation and examination (also
designated ‘Hours after Eimeria meleagrimitis inocula-
tion’) (categorical, 2 to 4 levels), turkey Age (binary) and
Experiment (categorical).
The effect of each of these study variables was analysed
under best possible control for the potentially influencing
effect of the other independent variables (control vari-
ables) on the frequency of severe lesions. Such control was
achieved by use of subsets of available data, where all
control variables were kept constant and similar for each
level of the study variable. As an example, the potential
impact of Challenge was controlled for by including only
turkeys from the same subsets of Eimeria meleagrimitis
dose, Hours after Eimeria meleagrimitis and Experiments
(Table 2).
Two-sided Fisher’s exact test or Pearson chi-square
test (tabulate procedure, Stata/MP 14.2) were used to
compare two groups, while Dunn’s test with Bonferroni
adjustment (dunntest procedure, Stata/MP 14.2) was
used for multiple comparisons. P-values below 0.05 were
considered statistically significant.
Relationships between study variables and oocyst excretion
The experimental unit was pooled samples of intestinal
contents from turkey groups defined during the analyses
of relationships between study variables and severe intestinal
lesions (see above, and Tables 2, 3 and 4). Pooled samples
were used to analyse the impact of independent variables on
OPG counts. OPG was a secondary (continuous) outcome
variable. Oocyst counts were log10-transformed. Outcome
estimates were reported as median log10 OPG counts.
The distribution of OPG counts within each turkey
group was in most cases non-normal (Shapiro-Wilk
normality test, swilk procedure in Stata 14.2). OPG data
were therefore analysed using non-parametric statistical
methods. Kruskal-Wallis rank test (kwallis procedure,
Stata/MP 14.2) was used to compare two groups, while
Dunn’s test with Bonferroni adjustment (dunntest proced-
ure, Stata/MP 14.2) was used for multiple comparisons. P-
values below 0.05 were considered statistically significant.
Comparison of statistical power of outcome variables
Data from experiment 9 were used. The unit of analysis
was individual turkeys. The study variable in this compari-
son was based on four combinations (designated groups in
Table 5) of turkey age and Clostridium perfringens inocula-
tion (0 = 3-week-old turkeys without Clostridium perfrin-
gens inoculation, 1 = 3-week-old turkey with Clostridium
perfringens inoculation, 2 = 5-week-old turkeys without
Clostridium perfringens inoculation, and 3 = 5-week-old
turkeys with Clostridium perfringens inoculation). Three
types of outcome variable were compared; frequency of
birds with score 3 lesions (severe lesions) per turkey group,
frequency of birds with intestinal pseudomembranes/ul-
cers-depressions per turkey group and median intestinal
scores (0–3 as defined in the developed scoring system) per
turkey group. Intestines were scored with pseudomem-
branes if apparently adherent mucoid and semisolid or dry
material was present (e.g. as in Fig. 1F). Ulcers/depressions
were scored if clearly demarcated mucosal depressions with
(ulcers) or without (depressions, see Fig. 1H) haemorrhage
were found.
Median rather than mean intestinal scores and non-
parametric testing was used because intestinal scores
were not normally distributed (Shapiro-Wilk normal-
ity test, swilk procedure in Stata/MP 14.2). Dunn’s
test with Bonferroni adjustment (dunntest procedure,
Stata/MP 14.2) for multiple comparisons was used for
analysis of impact of the study variable on all three
outcome variables. P-values below 0.05 were consid-
ered statistically significant.
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Supplementary information accompanies this paper at https://doi.org/10.
1186/s12917-020-2270-5.
Additional file 1. Additional photos of intestinal lesions. Folder with 47
additional photos in JPG format illustrating turkeys with intestinal lesions
that were assigned to scores 0, 1, 2 or 3.
Additional file 2. Data supporting conclusions regarding impact of
study variables on frequency of turkeys with severe intestinal lesions.
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